Search for Clinical Trial Results

Sponsored By

Kaposi Sarcoma - 25 Studies Found

Status Study
Recruiting Study Name: Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma
Condition: Kaposi Sarcoma
Date: 2017-02-09
Interventions: Device: Smartphone confocal microscopy Imaging of skin lesion using the smartphone confocal microscopy
Terminated Study Name: PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Kaposi's Sarcoma
Date: 2008-05-29
Interventions:
  • Drug: VEGF inhibitor PTC299 20
Completed Study Name: Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Date: 2011-02-15
Interventions: Drug: Bevacizumab Intralesional bevacizumab, dosis of 5mg/cm2, injections every 2 weeks, total number of
Completed Study Name: Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
Condition: Kaposi's Sarcoma
Date: 2010-12-20
Interventions: Drug: Maraviroc FDA Recommended dosing will be used in thi
Completed Study Name: Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Condition: Kaposi's Sarcoma
Date: 2010-02-10
Interventions: Drug: Indinavir in association with Vinblastina +/- Bleomicina Treatment consists in an induction phase
Completed Study Name: Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
Condition: Classical Kaposi's Sarcoma
Date: 2006-08-09
Interventions: Drug: indinavir
Completed Study Name: A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
Condition: AIDS-related Kaposi's Sarcoma
Date: 2009-02-02
Interventions:
  • Drug: abacavir/3TC/zidovudine

Recruiting Study Name: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Condition: Kaposi Sarcoma
Date: 2016-01-20
Interventions:
  • Drug: liposomal doxorubicin li
Completed Study Name: Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Condition: Kaposi's Sarcoma
Date: 2014-07-24
Interventions: Drug: Tc 99m tilmanocept Other Name: Lymphoseek
Terminated Study Name: A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
Condition: Kaposi Sarcoma
Date: 2011-08-08
Interventions: Drug: everolimus everolimus per os 10mg per day
Next >>>